Pharma Marketing News
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Conference Calendar Reader Surveys

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
Share |

FDA Draft Guidance for Print DTCA
Less than Feared

On February 4, 2004, the FDA issued long-awaited draft guidance documents designed to improve communications to consumers and health care practitioners about health conditions and medical products. The most eagerly anticipated guidance concerns the acceptable alternatives to the lengthy, detailed, and technically-written "brief summary" of risk information for consumer-directed print advertisements for prescription drugs.

This article reviews the new guidance and includes comments from Jack E. Angel, Executive Director of the Coalition for Healthcare Communication and Harry Sweeney, CEO of Dorland Global Health Communications.

Read this article now. It's FREE...

Download PDF file

PMN32-03
Issue: Vol. 3, No. 2: February 2004
Word Count: 1319

Find other articles in related Topic Areas:

Vol 3, #2 Contents









Search All Pharma Marketing News Pages

Pharma Marketing News Email Addr:  

Contact Information
Editor
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.